Investors are seeking business resilience in the sweet spot between responsible investing and FDI amid the Covid-19 crisis.
Business and agency leaders on why Costa Rica is a prime location for investors re-examining their site selection options as they seek to shorten and strengthen supply chains post-Covid-19.
Canada, Mexico, and Central and Eastern Europe are identified as three key regions that investors will turn to when looking to reduce their exposure to Asia.
Developing countries will face greater challenges to restarting their economies compared with their wealthy counterparts, based on the relative sizes of their Covid-19 stimulus packages.
With supply chains disrupted and the world veering all its attention towards halting Covid-19, FDI flows into the pharmaceutical sector will strongly depend on countries’ ability to respond to the epidemic, and their overall stability.